SCHEMBL7978906

SCHEMBL7978906

CC(c1ccc2ccccc2n1)c1ccccc1/C=C/[C]=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.37
▸ SMN1; SMN2 Q16637 4/20 0.37
▸ LMNA P02545 4/20 0.37
▸ MAPT P10636 4/20 0.37
▸ CYP1A2 P05177 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ NPC1 O15118 6/20 0.34
▸ RAB9A P51151 6/20 0.34
▸ ALDH1A1 P00352 4/20 0.34
▸ L3MBTL1 Q9Y468 3/20 0.34
▸ ECE2 P0DPD6 2/20 0.34
▸ PKM P14618 2/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7965579 0.77 CYP1A2 (0.35) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL7179138 0.73 GABRA1 (0.38) LMNAMAPTCYP1A2L3MBTL1MEN1
SCHEMBL7179143 0.73 GABRA1 (0.38) LMNAMAPTCYP1A2L3MBTL1MEN1
SCHEMBL8111110 0.70 CYP1A2 (0.35) LMNAMAPTCYP1A2ALDH1A1NFKB1
SCHEMBL7469957 0.67 S1PR3 (0.47) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL18426840 0.66 CYP1A2 (0.48) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL1261380 0.66 CYP1A2 (0.48) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL7978993 0.66 HDAC8 (0.42) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL827081 0.66 CYP1A2 (0.52) KDM4ESMN1; SMN2LMNAMAPTCYP1A2
SCHEMBL11663983 0.66 CYP1A2 (0.44) KDM4ESMN1; SMN2LMNAMAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 — — US disclosed
US-6127389-A TREATMENT OF HYPERTENSION, RENAL DISEASES, HEART FAILURE, HYPERTENSION, MENIERE'S DISEASE, PERIPHERAL AND CEREBRAL CIRCULATORY DISORDERS, CLIMACTERIC DISTURBANCE, RETINOCHOROIDAL CIRCULATORY DISORDERS, MYOCARDIAL ISCHEMIA FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-10-03 — — US disclosed
US-6083959-A BRADYKININ ANTAGONISTS; FOR THE PREVENTION AND/OR THE TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 — — US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 — — US disclosed
US-6015818-A TREATING KIDNEY, BRAIN, AND CARDIOVASCULAR DISORDERS; HYPOTENSIVE AGENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-01-18 — — US disclosed
EP-0900203-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-03-10 — — EP disclosed
EP-0879233-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-25 — — EP disclosed
WO-1997041104-A1 QUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-06 — — WO disclosed
WO-1997028153-A1 CHINOLINE AND BENZIMIDAZOLE DERIVATIVES AS BRADYKININ AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-08-07 — — WO disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 — — EP disclosed
Send feedback